We are live on ! Find out more
BIIB icon

Biogen

782 hedge funds and large institutions have $68.4B invested in Biogen in 2014 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 275 increasing their positions, 302 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 69

9% more funds holding in top 10

Funds holding in top 10: 3336 (+3)

4% more capital invested

Capital invested by funds: $66.1B → $68.4B (+$2.35B)

1% more funds holding

Funds holding: 776782 (+6)

9% less repeat investments, than reductions

Existing positions increased: 275 | Existing positions reduced: 302

25% less call options, than puts

Call options by funds: $814M | Put options by funds: $1.09B

Holders
782
Holders Change
+6
Holders Change %
+0.77%
% of All Funds
22.48%
Holding in Top 10
36
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+9.09%
% of All Funds
1.03%
New
81
Increased
275
Reduced
302
Closed
69
Calls
$814M
Puts
$1.09B
Net Calls
-$271M
Net Calls Change
+$35.6M
Name Holding Trade Value Shares
Change
Change in
Stake
GC
776
Globeflex Capital
California
$3K -$301 -1 -8%
EWM
777
Edge Wealth Management
New York
$3K
MAS
778
Madden Advisory Services
Florida
$3K
QAM
779
QCI Asset Management
New York
$3K
FMII
780
Farmers & Merchants Investments Inc
Nebraska
$2K
PMAM
781
Picton Mahoney Asset Management
Ontario, Canada
$1.51K +$1.44M +4,800 New
PAS
782
Partnervest Advisory Services
California
$1K
Viking Global Investors
783
Viking Global Investors
Connecticut
-$119M -388,900 Closed
SCA
784
SAC Capital Advisors
Connecticut
-$79.2M -258,862 Closed
CM
785
Castleark Management
Illinois
-$41.2M -134,770 Closed
CGM
786
Capital Growth Management
Massachusetts
-$35.5M -116,000 Closed
TCP
787
Tourbillon Capital Partners
New York
-$18.4M -60,000 Closed
WI
788
Wafra Inc
New York
-$16M -52,400 Closed
SCM
789
Sigma Capital Management
Connecticut
-$9.79M -32,000 Closed
CEP
790
Chicago Equity Partners
Illinois
-$7.12M -23,265 Closed
SAM
791
Senzar Asset Management
New York
-$5.57M -18,200 Closed
CII
792
CR Intrinsic Investors
Connecticut
-$3.98M -13,000 Closed
HT
793
HAP Trading
New York
-$3.87M -12,855 Closed
DM
794
Deerfield Management
New York
-$3.59M -11,750 Closed
DSI
795
Daiwa SB Investments
Japan
-$3.12M -10,210 Closed
AC
796
Ascend Capital
California
-$3.06M -10,010 Closed
CANY
797
Caxton Associates (New York)
New York
-$3.06M -10,000 Closed
CAM
798
Cormorant Asset Management
Massachusetts
-$3.06M -10,000 Closed
NCGI
799
Next Century Growth Investors
Minnesota
-$2.95M -9,646 Closed
ACM
800
Atika Capital Management
New York
-$2.6M -8,500 Closed

BIIB Hedge Fund Activity: Q2 2014 in Review

782 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q2 2014, worth a combined $68.4B — up 3.6% from $66.1B a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new BIIB positions and 69 closed out — a net gain of 12 holders — while 275 added to existing stakes and 302 trimmed.

The largest buyer was Norges Bank, adding an estimated $493M. The largest seller was Wellington Management Group, cutting an estimated $253M.

  • 782 institutional investors held Biogen (BIIB) as of Q2 2014, up from 776 in Q1 2014.
  • Funds reported $68.4B of Biogen stock for Q2 2014, up 3.6% quarter-over-quarter.
  • 81 funds opened new Biogen positions in Q2 2014 and 69 closed out, a net change of +12 holders.
  • The largest Biogen buyer in Q2 2014 was Norges Bank, an estimated $493M added.
  • The largest Biogen seller in Q2 2014 was Wellington Management Group, an estimated $253M sold.

Based on aggregated 13F filings for Q2 2014.